Skip to main content

Steve Kelsey

Equibles does not estimate personal net worth.

About Steve Kelsey

The proxy statement of Revolution Medicines, Inc. reports total compensation of $5,949,607 for Steve Kelsey in fiscal 2024, including a base salary of $573,333. Disclosed compensation is on record for 6 fiscal years. Steve Kelsey has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Revolution Medicines, Inc. on May 31, 2026. The companies whose calls Steve Kelsey spoke on are classified in the Healthcare sector.

Steve Kelsey on recent calls

“I mean, we generated a fairly substantial body of phase 1-2 data before we started most of our phase 3 studies, with the possible exception of the 304 study, which we inferred from the phase 1-2 data that we already had in both second-line plus and first-line pancreatic cancer.”
Other, Revolution Medicines Conference Call ·
“Thank you. high commitment first line maybe the reality is that there are a number of options available to us we continue to optimize direct somracid in combination with the combination partners that you might expect us to use for that indication and also do efficacy testing to get the requisite proof of concept…”
Other, Revolution Medicines, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Revolution Medicines, Inc. (RVMD) $573,333 $5,949,607
2023 Revolution Medicines, Inc. (RVMD) $512,575 $4,394,499
2022 Revolution Medicines, Inc. (RVMD) $497,500 $3,083,099
2021 Revolution Medicines, Inc. (RVMD) $482,333 $2,896,305
2020 Revolution Medicines, Inc. (RVMD) $464,210 $1,262,469
2019 Revolution Medicines, Inc. (RVMD) $424,350 $1,895,403

Recent activity